UBS Maintains Neutral on Gentex, Lowers Price Target to $25

Benzinga Newsdesk www.benzinga.com Negative 89.6%

Neg 89.6% Neu 0% Pos 0%

UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $26 to $25.

Comments

No comments yet. Be the first!